ASCO® 2025 Highlights: Presenter Vignette – Sheraz Yaqub
Sheraz Yaqub
MD, PhD, FEBS
Oslo University Hospital
LBA3511
Aspirin as secondary prevention for colorectal cancer liver metastases (ASAC): A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.
Interested in learning more about these abstracts and other trials presented at ASCO® 2025? Be sure to register for one of our licensed Best of ASCO® events in a city near you.
This program has been made possible through unrestricted support from Boehringer Ingelheim, Eli Lilly and Ipsen
